Robert Meyer

Dr. Robert J.
Meyer, MD, is an Independent Director at Avalyn Pharma, Inc., a Principal-Drug & Biological Products at Greenleaf Health Inc. and an Associate Professor-Public Health Sciences at University of Virginia.
He is on the Board of Directors at Avalyn Pharma, Inc. Dr. Meyer was previously employed as an Independent Director by Translate Bio, Inc., an Independent Director by Chimerix, Inc., a Trustee by The United States Pharmacopeia, a VP, Head-Global Regulatory Strategy & Policy by Merck & Co., Inc., a VP, Head-Global Regulatory Strategy & Policy by Merck Research Laboratories Massachusetts LLC, a Director-Drug Evaluation & Research by US Food & Drug Administration, and a Director-Office Drug Evaluation II by Center for Drug Evaluation & Research.
He also served on the board at Correvio Pharma Corp.
and Virginia Center For Translational & Regulatory Sciences.
He received his undergraduate degree from Lehigh University and a doctorate degree from The University of Connecticut School of Medicine.